Savitch v. Federal Trade Commission

218 F.2d 817
CourtCourt of Appeals for the Second Circuit
DecidedJanuary 26, 1955
DocketNo. 125, Docket 23102
StatusPublished
Cited by1 cases

This text of 218 F.2d 817 (Savitch v. Federal Trade Commission) is published on Counsel Stack Legal Research, covering Court of Appeals for the Second Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Savitch v. Federal Trade Commission, 218 F.2d 817 (2d Cir. 1955).

Opinion

PER CURIAM.

The Commission’s conclusion, contrary to that of its Hearing Examiner, that petitioners had at least indirectly represented their product to be an abortifacient, was a reasonable interpretation of petitioners’ advertise[818]*818ment, which we accept in the light of the Commission’s special expertise' and responsibility in the premises. There was sufficient evidence. to support the finding that borderline anemia would not in itself cause delayed menstruation, and both the Commission and the Hearing Examiner agreed that petitioners’ product would not be immediately effective to overcome other minor functional disorders. Consequently the Commission’s order must be enforced.'

Decision affirmed; enforcement granted.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
218 F.2d 817, Counsel Stack Legal Research, https://law.counselstack.com/opinion/savitch-v-federal-trade-commission-ca2-1955.